{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Familial pulmonary fibrosis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_abatacept",
          "name": "Abatacept"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_anakinra",
          "name": "Anakinra"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_daclizumab",
          "name": "Daclizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_teriflunomide",
          "name": "Teriflunomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_pb",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial Pulmonary Fibrosis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target1",
          "type": "Target",
          "label": "CD80",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "TNF-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target3",
          "type": "Target",
          "label": "IL-1",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target4",
          "type": "Target",
          "label": "Cytotoxic T lymphocyte antigen 4 (CTLA-4)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target5",
          "type": "Target",
          "label": "Fibroblast Growth Factor Receptors (FGFRs)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target6",
          "type": "Target",
          "label": "PDGF Receptors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_abatacept",
          "type": "Target",
          "label": "Abatacept Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_abatacept",
          "type": "Pathway",
          "label": "Abatacept Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_abatacept",
          "type": "Phenotype",
          "label": "Adverse Effect from Abatacept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "Adalimumab Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "Adalimumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "Adverse Effect from Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_anakinra",
          "type": "Target",
          "label": "Anakinra Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_anakinra",
          "type": "Pathway",
          "label": "Anakinra Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_anakinra",
          "type": "Phenotype",
          "label": "Adverse Effect from Anakinra",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_azathioprine",
          "type": "Target",
          "label": "Azathioprine Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_azathioprine",
          "type": "Pathway",
          "label": "Azathioprine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_azathioprine",
          "type": "Phenotype",
          "label": "Adverse Effect from Azathioprine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_bosentan",
          "type": "Target",
          "label": "Bosentan Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_bosentan",
          "type": "Pathway",
          "label": "Bosentan Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_bosentan",
          "type": "Phenotype",
          "label": "Adverse Effect from Bosentan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclophosphamide",
          "type": "Target",
          "label": "Cyclophosphamide Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclophosphamide",
          "type": "Pathway",
          "label": "Cyclophosphamide Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclophosphamide",
          "type": "Phenotype",
          "label": "Adverse Effect from Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_daclizumab",
          "type": "Target",
          "label": "Daclizumab Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_daclizumab",
          "type": "Pathway",
          "label": "Daclizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_daclizumab",
          "type": "Phenotype",
          "label": "Adverse Effect from Daclizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "Methotrexate Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "Methotrexate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "Adverse Effect from Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_nintedanib",
          "type": "Target",
          "label": "Nintedanib Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_nintedanib",
          "type": "Pathway",
          "label": "Nintedanib Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_nintedanib",
          "type": "Phenotype",
          "label": "Adverse Effect from Nintedanib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_pirfenidone",
          "type": "Target",
          "label": "Pirfenidone Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_pirfenidone",
          "type": "Pathway",
          "label": "Pirfenidone Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_pirfenidone",
          "type": "Phenotype",
          "label": "Adverse Effect from Pirfenidone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_rituximab",
          "type": "Target",
          "label": "Rituximab Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_rituximab",
          "type": "Pathway",
          "label": "Rituximab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_rituximab",
          "type": "Phenotype",
          "label": "Adverse Effect from Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_teriflunomide",
          "type": "Target",
          "label": "Teriflunomide Off Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_teriflunomide",
          "type": "Pathway",
          "label": "Teriflunomide Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_teriflunomide",
          "type": "Phenotype",
          "label": "Adverse Effect from Teriflunomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Abatacept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_abatacept",
          "type": "Drug",
          "label": "Abatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Anakinra",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_anakinra",
          "type": "Drug",
          "label": "Anakinra",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Bosentan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Daclizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_daclizumab",
          "type": "Drug",
          "label": "Daclizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Nintedanib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_pirfenidone",
          "type": "Drug",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_teriflunomide",
          "type": "Drug",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_abatacept",
          "target": "n_target4",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "CTLA-4 modulation indicated for immune-related diseases"
        },
        {
          "source": "n_target4",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Involved in immune response pathways"
        },
        {
          "source": "n_pb",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Pathway implicated in pulmonary fibrosis"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "TNF-alpha inhibition relevant to fibrosis"
        },
        {
          "source": "n_target2",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Link to fibrogenic processes"
        },
        {
          "source": "drug_anakinra",
          "target": "n_target3",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "IL-1 inhibition shown in fibrosis"
        },
        {
          "source": "n_target3",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Modulates inflammatory response"
        },
        {
          "source": "drug_bosentan",
          "target": "n_target5",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "FGFR inhibition has fibrotic implications"
        },
        {
          "source": "drug_nintedanib",
          "target": "n_target6",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "PDGF receptor antagonism known for fibrosis"
        },
        {
          "source": "n_target6",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Involved in pulmonary fibrotic progression"
        },
        {
          "source": "drug_pirfenidone",
          "target": "n_target5",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "FGF inhibition linked to antifibrotic effects"
        },
        {
          "source": "drug_abatacept",
          "target": "n_ot_abatacept",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能影响肺部功能"
        },
        {
          "source": "n_ot_abatacept",
          "target": "n_rp_abatacept",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与纤维化风险链相关"
        },
        {
          "source": "n_rp_abatacept",
          "target": "n_adv_abatacept",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_adv_abatacept",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "证明潜在风险对治疗效果的否定"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与疾病机制冲突"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与肺纤维化风险通路有关"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引发严重不良反应"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险可能抵消治疗的对照效果"
        },
        {
          "source": "drug_anakinra",
          "target": "n_ot_anakinra",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "机理类似可能加重心肺症状"
        },
        {
          "source": "n_ot_anakinra",
          "target": "n_rp_anakinra",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "相关风险可能加剧病程"
        },
        {
          "source": "n_rp_anakinra",
          "target": "n_adv_anakinra",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "引起肺部并发症的可能性"
        },
        {
          "source": "n_adv_anakinra",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险会影响治疗效果"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_ot_azathioprine",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与免疫抑制类药物风险有关"
        },
        {
          "source": "n_ot_azathioprine",
          "target": "n_rp_azathioprine",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能导致肺纤维化加重"
        },
        {
          "source": "n_rp_azathioprine",
          "target": "n_adv_azathioprine",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引起肺部不良反应"
        },
        {
          "source": "n_adv_azathioprine",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "加重肺纤维化的机制存疑"
        },
        {
          "source": "drug_bosentan",
          "target": "n_ot_bosentan",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能引发心肺毒性"
        },
        {
          "source": "n_ot_bosentan",
          "target": "n_rp_bosentan",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "风险通路可能与疾病相关"
        },
        {
          "source": "n_rp_bosentan",
          "target": "n_adv_bosentan",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "引发严重不良反应"
        },
        {
          "source": "n_adv_bosentan",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "严重不良反应会减少治疗潜力"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_ot_cyclophosphamide",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在副作用可能加重肺部病变"
        },
        {
          "source": "n_ot_cyclophosphamide",
          "target": "n_rp_cyclophosphamide",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "相关风险和疗效不一致"
        },
        {
          "source": "n_rp_cyclophosphamide",
          "target": "n_adv_cyclophosphamide",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能导致严重不良反应"
        },
        {
          "source": "n_adv_cyclophosphamide",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "很可能抵消临床效益"
        },
        {
          "source": "drug_daclizumab",
          "target": "n_ot_daclizumab",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "机理不一定适合该疾病"
        },
        {
          "source": "n_ot_daclizumab",
          "target": "n_rp_daclizumab",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能与纤维化加重有关"
        },
        {
          "source": "n_rp_daclizumab",
          "target": "n_adv_daclizumab",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引发重大肺部不良反应"
        },
        {
          "source": "n_adv_daclizumab",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在风险疑似抵消治疗益处"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能会损害肺功能"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能与肺部风险链有关"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引发严重肺部不良反应"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗效益"
        },
        {
          "source": "drug_nintedanib",
          "target": "n_ot_nintedanib",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "考虑到对肺部的作用"
        },
        {
          "source": "n_ot_nintedanib",
          "target": "n_rp_nintedanib",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与可能加重纤维化风险相关"
        },
        {
          "source": "n_rp_nintedanib",
          "target": "n_adv_nintedanib",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引发不良肺部反应"
        },
        {
          "source": "n_adv_nintedanib",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险链可能威胁疗效"
        },
        {
          "source": "drug_pirfenidone",
          "target": "n_ot_pirfenidone",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抑制肺部修复"
        },
        {
          "source": "n_ot_pirfenidone",
          "target": "n_rp_pirfenidone",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "引发肺部问题"
        },
        {
          "source": "n_rp_pirfenidone",
          "target": "n_adv_pirfenidone",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能导致不良肺部反应"
        },
        {
          "source": "n_adv_pirfenidone",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能降低净获益"
        },
        {
          "source": "drug_rituximab",
          "target": "n_ot_rituximab",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能引发免疫抑制反应"
        },
        {
          "source": "n_ot_rituximab",
          "target": "n_rp_rituximab",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "风险与疾病相冲突"
        },
        {
          "source": "n_rp_rituximab",
          "target": "n_adv_rituximab",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引发严重不良反应"
        },
        {
          "source": "n_adv_rituximab",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "将降低治疗效果"
        },
        {
          "source": "drug_teriflunomide",
          "target": "n_ot_teriflunomide",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能损害免疫功能"
        },
        {
          "source": "n_ot_teriflunomide",
          "target": "n_rp_teriflunomide",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能对肺部功能造成影响"
        },
        {
          "source": "n_rp_teriflunomide",
          "target": "n_adv_teriflunomide",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能引发肺部不良反应"
        },
        {
          "source": "n_adv_teriflunomide",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "呼吸道并发症风险可能影响效益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_abatacept",
          "name": "Abatacept"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H1_round3",
        "key_assumptions": [
          "Abatacept potentially disrupts immune modulation in pulmonary fibrosis",
          "The adverse effects identified could compromise treatment efficacy"
        ],
        "caveats": [
          "Long-term effects of Abatacept in pulmonary fibrosis are uncertain"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "score": 0.63,
        "graph_snapshot_ref": "GE_H2_round3",
        "key_assumptions": [
          "Adalimumab's TNF-alpha inhibition could be beneficial",
          "Adverse events pose significant risks"
        ],
        "caveats": [
          "Potential conflict with disease mechanisms remains a concern"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_anakinra",
          "name": "Anakinra"
        },
        "score": 0.62,
        "graph_snapshot_ref": "GE_H3_round3",
        "key_assumptions": [
          "IL-1 inhibition may play a role in fibrosis control",
          "Increased risk of respiratory complications must be considered"
        ],
        "caveats": [
          "The safety profile in the context of this disease is unclear"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "score": 0.58,
        "graph_snapshot_ref": "GE_H4_round3",
        "key_assumptions": [
          "Myelosuppressive risk factors are critical",
          "Impacts on pulmonary fibrosis need careful evaluation"
        ],
        "caveats": [
          "Potential exacerbation of pulmonary fibrosis is a serious concern"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "score": 0.57,
        "graph_snapshot_ref": "GE_H5_round3",
        "key_assumptions": [
          "Fibrotic effects of bosentan correlate with pulmonary function impairment",
          "Adverse effects are significant considerations"
        ],
        "caveats": [
          "Concerns about long-term pulmonary safety persist"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "score": 0.55,
        "graph_snapshot_ref": "GE_H6_round3",
        "key_assumptions": [
          "Potential for enhanced pulmonary damage",
          "Severe adverse reactions are a significant risk"
        ],
        "caveats": [
          "Conflict between risk and treatment efficacy exists"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_daclizumab",
          "name": "Daclizumab"
        },
        "score": 0.54,
        "graph_snapshot_ref": "GE_H7_round3",
        "key_assumptions": [
          "Mechanisms might not be appropriate for this condition",
          "Associated risks must be carefully monitored"
        ],
        "caveats": [
          "Long-term efficacy remains uncertain in the context of pulmonary fibrosis"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.53,
        "graph_snapshot_ref": "GE_H8_round3",
        "key_assumptions": [
          "Risk of pulmonary function impairment is significant",
          "Careful evaluation of adverse effects needed"
        ],
        "caveats": [
          "The impact on treatment efficacy needs further assessment"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "score": 0.52,
        "graph_snapshot_ref": "GE_H9_round3",
        "key_assumptions": [
          "PDGF receptor antagonism has implications for fibrosis",
          "Adverse reactions require further investigation"
        ],
        "caveats": [
          "Uncertainty around the risk-benefit ratio exists"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "score": 0.51,
        "graph_snapshot_ref": "GE_H10_round3",
        "key_assumptions": [
          "Counteracting fibrosis is a key target",
          "Adverse pulmonary reactions are concerning"
        ],
        "caveats": [
          "The overall treatment impact needs careful scrutiny"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "score": 0.5,
        "graph_snapshot_ref": "GE_H11_round3",
        "key_assumptions": [
          "Immunosuppressive characteristics must be monitored",
          "Potentially conflicting mechanisms with fibrotic conditions"
        ],
        "caveats": [
          "Overall treatment efficacy could be diminished"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H12",
        "candidate": {
          "id": "drug_teriflunomide",
          "name": "Teriflunomide"
        },
        "score": 0.49,
        "graph_snapshot_ref": "GE_H12_round3",
        "key_assumptions": [
          "Immune system modulation may affect disease progression",
          "Negative impact on lung function is a concern"
        ],
        "caveats": [
          "The efficacy in this context remains questionable"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target→Pathway→Disease",
          "reason": "Adverse effects show strong negation of treatment efficacy"
        }
      ],
      "remaining_gaps": [
        "Conflict hotspots in the efficacy and safety relations remain unaddressed"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "Addressed key mechanistic pathways for candidate drugs."
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "Clarified safety concerns tied to adverse reactions."
        }
      ],
      "lessons": [
        "Address conflicting risk factors when evaluating drug therapy.",
        "Focusing on drug mechanisms relevant to pulmonary fibrosis improves investigation."
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "Ensure links to pathway and targets are tightly connected to proposed benefits."
      },
      {
        "role": "Skeptic",
        "patch": "Highlight critical evidence for potential adverse effects to advance understanding."
      },
      {
        "role": "Explorer",
        "patch": "Retain consistency with indications of interest; prioritize addressing gaps in data."
      }
    ],
    "heuristics": [
      {
        "when": "pulmonary complications arise",
        "then": "Evaluate impact vs. damage ratio for therapies in fibrosis contexts."
      },
      {
        "when": "mechanism classifications overlap",
        "then": "Consider further splits to clarify distinct risk profiles among candidates."
      }
    ]
  }
}